> Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an in

> Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the optic nerve of the eye [NAION], which can lead to severe and permanent loss of vision. > The condition [NAION] is often developed by patients who are at particular risk of cardiovascular disease. The risk factors are diabetes, high blood pressure and high cholesterol. Patients affected by the condition also tend to have some physical conditions in the eye, which can be the triggering factor.